Dr. Amaria on Genetically Modified TILs in Melanoma
1 Tampilan
• 07/03/23
0
0
Menanamkan
administrator
Pelanggan
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru